FGFR4 transmembrane domain polymorphism and cancer risk: A meta-analysis including 8555 subjects

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3332-3338

  Xu, Wei ^a   Li, Yan ^a   Wang, Xueli ^a   Chen, Bo ^a   Wang, Yan ^a   Liu, Shifeng ^a   Xu, Jijun ^a   Zhao, Weihong ^a   Wu, Jianqing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma; FGFR4; Genetic polymorphism; Meta analysis; Susceptibility

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 4;

ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNICITY; FEMALE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; SYSTEMATIC REVIEW;

FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RISK FACTORS;

EID: 78649631410     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.06.017     Document Type: Article

References (40)

1. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
2. K.S. Kolibaba, and B.J. Druker Protein tyrosine kinases and cancer Biochim Biophys Acta 1333 1997 217 248
3. B. Kwabi-Addo, M. Ozen, and M. Ittmann The role of fibroblast growth factors and their receptors in prostate cancer Endocr Relat Cancer 11 2004 709 724
4. V.P. Eswarakumar, I. Lax, and J. Schlessinger Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev 16 2005 139 149
5. S. Raffioni, D. Thomas, and E.D. Foehr Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells PNAS 96 1999 7178 7183
6. C.L. Johnston, H.C. Cox, and J.J. Gomm bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement Biochem J 306 1995 609 616
7. S. Jaakkola, P. Salmikangas, and S. Nylund Amplification of fgfr4 gene in human breast and gynecological cancers Int J Cancer 54 1993 378 382
8. K. Sahadevan, S. Darby, and H.Y. Leung Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer J Pathol 213 2007 82 90
9. H.K. Ho, S. Pok, and S. Streit Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention J Hepatol 50 2009 118 127
10. H.Y. Leung, W.J. Gullick, and N.R. Lemoine Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer Int J Cancer 59 1994 667 675
11. A. Takahashi, H. Sasaki, and S.J. Kim Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique Biochem Biophys Res Commun 257 1999 855 859
12. S. Streit, D.S. Mestel, and M. Schmidt FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients Brit J Cancer 94 2006 1879 1886
13. J. Bange, D. Prechtl, and Y. Cheburkin Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele Cancer Res 62 2002 840 847
14. M. Spinola, V.P. Leoni, and J. Tanuma FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer Oncol Rep 14 2005 415 419
15. C. Thussbas, J. Nahrig, and S. Streit FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer J Clin Oncol 24 2006 3747 3755
16. P. JézéQuel, L. Campion, and M.P. Joalland G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis Brit J Cancer 90 2004 189 193
17. R. Naidu, Y.C. Har, and N.A. Taib Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development Oncol Res 18 2009 65 71
18. J. Wang, W. Yu, and Y. Cai Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression Neoplasia 10 2008 847 856
19. J. Wang, D.W. Stockton, and M. Ittmann The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression Clin Cancer Res 10 2004 6169 6178
20. Z. Ma, N. Tsuchiya, and T. Yuasa Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population Int J Cancer 123 2008 2574 2579
21. L.M. FitzGerald, E. Karlins, and D.M. Karyadi Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis Prostate Cancer Prostatic Dis 12 2009 192 197
22. C.K. Ho, S. Anwar, and J. Nanda FGFR4 Gly(388)Arg polymorphism and prostate cancer risk in Scottish men Prostate Cancer Prostatic Dis 13 2010 94 96
23. S. Streit, J. Bange, and A. Fichtner Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma Int J Cancer 111 2004 213 217
24. V.C. Da Costa Andrade, O. Parise Jr, and C.P. Hors The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma Exp Mol Pathol 82 2007 53 57
25. A. Ansell, L. Farnebo, and R. Grénman Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer Oral Oncol 45 2009 23 29
26. C. Mawrin, E. Kirches, and S. Diete Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas Cancer Lett 239 2006 239 245
27. J. Tanuma, T. Izumo, and M. Hirano FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma Oncol Rep 23 2010 739 744
28. A. Matakidou, R. El Galta, and M.F. Rudd Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis Brit J Cancer 96 2007 1904 1907
29. F.S. Falvella, E. Frullanti, and A. Galvan FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung Int J Cancer 124 2009 2880 2885
30. M. Spinola, V. Leoni, and C. Pignatiello Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients J Clin Oncol 23 2005 7307 7311
31. Yang Y. Association of fibroblast growth factor receptor 4 genetic polymorphisms with hepatocellular carcinoma susceptibility. PhD thesis. The Second Military Medical University, Doctoral Dissertation full-text database of China; 2008.
32. H. Nan, A.A. Qureshi, and D.J. Hunter Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study BMC Cancer 9 2009 171 176
33. Y.C. Yang, M.L. Lu, and J.Y. Rao Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis Brit J Cancer 95 2006 1455 1458
34. Y. Morimoto, T. Ozaki, and M. Ouchida Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma Cancer 98 2003 2245 2250
35. W.G. Cochran The combination of estimates from different experiments Biometrics 10 1954 101 129
36. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
37. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
38. M. Egger, G. Davey Smith, and M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
39. J.H. Jang, K.H. Shin, and J.G. Park Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers Cancer Res 61 2001 3541 3543
40. C.J. Powers, S.W. McLeskey, and A. Wellstein Fibroblast growth factors, their receptors and signaling Endocr Relat Cancer 7 2000 165 197